Researches say gene therapy trials for heart disease show promising results, despite FDA "caution"
This article was originally published in Clinica
Executive Summary
Preliminary evidence from trials of gene therapy for coronary heart disease shows that the technique is safe and could be efficacious, said angiogenesis pioneer Jeffrey Isner at the American College of Cardiology meeting in Anaheim, California, last week.